%0 Journal Article
%T Evaluaci¨®n positiva de medicamentos: 2o Trimestre 2012
%A Garc¨ªa Luque
%A A.
%A Puerro Vicente
%A M.
%A S¨¢nchez L¨®pez
%A P.
%A Cabanes Mariscal
%A M.A.
%J Sanidad Militar
%D 2012
%I Ministerio de Defensa
%R 10.4321/S1887-85712012000300009
%X the drugs assessed by the spanish agency for medicines and health products made public in the second quarter of 2012, and considered of interest to the healthcare professional, are reviewed. these are positive technical reports prior to the authorization and placing on the market of the product.
%K axitinib
%K inlyta
%K aclidinio bromuro
%K eklira
%K bretaris genuair
%K glicopirronio
%K enurev
%K seebri
%K tovanor
%K breezhaler
%K catridecacog
%K novothirteen
%K ceftarolina fosamil
%K zinforo
%K cobre (64cu) cloruro de
%K cuprymina
%K dapaglifocina
%K forxiga
%K ferumoxytol
%K rienso
%K ivacaftor
%K yervoy
%K linagliptina/metformina hidrocloruro
%K jentadueto
%K perampanel
%K fycompa
%K ruxolitinib
%K jakavi
%K teduglutida
%K revestive.
%U http://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1887-85712012000300009&lng=en&nrm=iso&tlng=en